Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular CarcinomaWenjiao Jin, Hong Li|International Journal of Biological Sciences|2023Cited by 19